Skip to main content

Peyronie’s Disease and Other Anatomical Disorders

  • Chapter
Management of Sexual Dysfunction in Men and Women

Abstract

Disorders of penile anatomy comprise a variety of presentations that produce physical and psychological deficits in men. While congenital disorders like chordee and hypospadias contribute, the acquired condition Peyronie’s disease is by far the most commonly seen penile anatomical disorder. This chapter provides a contemporary review of the pathophysiology, diagnosis, and management of these conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991;146(4):1007–9.

    CAS  PubMed  Google Scholar 

  2. Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie’s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007;19(2):213–7 [Epub 2006 Aug 17].

    Article  CAS  PubMed  Google Scholar 

  3. El-Sakka AI. Prevalence of Peyronie’s disease among patients with erectile dysfunction. Eur Urol. 2006;49(3):564–9 [Epub 2005 Dec 19].

    Article  PubMed  Google Scholar 

  4. Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie’s disease: prevalence and treatment patterns in the United States. Adv Urol. 2011;2011:282503 [Epub 2011 Oct 23].

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88(7):727–30.

    Article  CAS  PubMed  Google Scholar 

  6. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F, SIMONA Study Group. Peyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. Eur Urol. 2001;40(5):525–30.

    Article  PubMed  Google Scholar 

  7. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171(6 Pt 1):2350–3.

    Article  PubMed  Google Scholar 

  8. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie’s disease. J Urol. 2006;175(6):2115–8; discussion 2118.

    Google Scholar 

  9. Mulhall JP. Implications of basic science research in Peyronie’s disease. In: Levine L, editor. Peyronie’s disease: a guide to clinical management. Totowa, NJ: Humana Press Inc.; 2007. p. 39–57.

    Chapter  Google Scholar 

  10. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008;5(8):1985–90 [Epub 2008 June 28].

    Article  PubMed  Google Scholar 

  11. Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie’s disease: validation of the Peyronie’s disease questionnaire. J Urol. 2013;190(2):627–34 [Epub 2013 Jan 31].

    Article  PubMed  Google Scholar 

  12. Serefoglu EC, Trost L, Sikka SC, Hellstrom WJ. The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease. Int J Impot Res. 2015;27(1):6–8.

    Google Scholar 

  13. Levine L. Understanding Peyronie’s disease. Omaha, NE: Addicus Books; 2007.

    Google Scholar 

  14. Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, Jones N, Kaufman GJ, Carson 3rd CC. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199–207 [Epub 2013 Jan 31].

    Article  CAS  PubMed  Google Scholar 

  15. Jordan GH, Carson CC, Lipshultz LI. Minimally invasive treatment of Peyronie’s disease: evidence-based progress. BJU Int. 2014;114(1):16–24.

    Article  PubMed  Google Scholar 

  16. Gelbard M. Correction of penile curvature using tunica albuginea plication, flaps, and expansion with fascial grafts. In: Ehrlich R, Alter G, editors. Reconstructive and plastic surgery of the external genitalia: adult and pediatric. Philadelphia: W.B. Saunders Company; 1999. p. 479–88.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin K. Gelbard M.D. .

Editor information

Editors and Affiliations

Appendices

Commentary: Peyronie’s Disease and Other Anatomical Disorders

When considered superficially, Peyronie’s disease and other conditions that result in penile curvature or deformity may be considered “minor” issues in a man’s sexual health. After all, penile curvature is often imminently treatable, whether using medication or via a surgical approach, and minor penile curvature may not be so severe as to impact sexual function. Often, little consideration is given to the psychological ramifications of conditions that alter penile anatomy. This may be in part due to the private nature of these conditions and the reluctance of men to talk about them. One should also not overlook the fact that the physicians treating these conditions—urologists—often approach them from a physical perspective, seeking to address the condition directly with the assumption that this will result in cure.

In the preceding chapter, the organic etiologies and treatment approaches to penile deformities, in particular Peyronie’s disease, are laid out in detail. What most clinicians do not consider, however, is the significant psychological impact that Peyronie’s disease can have on affected men, with many of these men having depressive symptoms and relationship issues attributable to their penile deformity. The following commentary, however, outlines the current knowledge on the psychological impact of Peyronie’s disease, showing just how potently affected these men can be. Knowing that penile deformity can significantly alter a man’s psychological perspectives and deeply affect his relationships is worthwhile for the clinician and should prompt a discussion with the patient about these often overlooked aspects of these conditions. Only by understanding the global impact of penile deformity on the patient’s condition can appropriate, truly curative, treatment be implemented.

The Editors

Commentary

It should not be surprising that many men experience distress related to Peyronie’s disease (PD). Gelbard and colleagues were the first to characterize the psychological impact of PD in 1990 [1]. They conducted a survey of 97 men with PD that included an assessment of “psychological effects” and reported that 77 % indicated a psychological impact from their PD. Of these men, 36 % indicated that the psychological impact remained the same and did not improve with time, while 36 % said that is worsened [1]. Even of the men who had improvement in their PD symptoms, up to half indicated that they worried about the PD “frequently” or “all the time.”

A study by Smith and colleagues supports the results of the Gelbard study. Smith et al. discovered that over 80 % of men reported “emotional difficulties” related to their PD [2]. Importantly, 50 % of men endorsed relationship problems due to PD. Smith and colleagues also identified possible predictors of this distress. The presence of relationship problems and loss of penile length were significant and independent predictors of emotional problems due to PD. Likewise, emotional difficulties and the inability to have intercourse were independent predictors of relationship problems. To address these psychological problems, the authors suggested that physicians integrate a psychosocial evaluation early in the assessment phase of PD to facilitate referrals for appropriate mental health therapy [2].

Nelson and colleagues sought to specifically assess the level of depression that men with PD experience. In 92 patients with PD, 48 % of men reported clinically meaningful depression (26 % moderate; 21 % severe) [3]. Men who were single and self-reported greater loss of penile length were more likely to also report depressive symptoms. In support of the Gelbard study discussed above, the analyses showed that depression remained consistently high over time, regardless of length of time since diagnosis of PD. The authors argue that physicians should go beyond the role of treating the PD and facilitate proper evaluation and treatment of the emotional and relationship ramifications of the disease [3].

Rosen and colleagues conducted a qualitative study to better understand men’s experience with PD, highlighting important concerns among men with PD [4]. Men reported significant distress related to the physical appearance of their penis. Regardless of the severity of their PD, the psychological distress was consistently high for all affected men. Some men expressed that “even looking at or touching their penis was unpleasant.” Men with PD described feelings of shame and inadequacy and discussed how PD impacted their masculinity, stating that they felt like “less of a man” as a consequence of their penile deformity. Men reported a decreased sense of sexual attractiveness, sexual interest, and sexual confidence. As a result, patients were hesitant to initiate sexual relations with a partner, while single men avoided dating. The feelings of bother in men with PD were extreme and highly distressing [4].

All men reported a significant decrease in their sexual satisfaction since the onset of PD. Many reported that PD impacted other aspects of their sexuality as well and endorsed an increase in performance anxiety in addition to difficulties with erection, ejaculation, or other aspects of sexual function [4]. Practically all men with PD were afraid that they were not satisfying their partners sexually, although none had sought counseling together with their partners. Importantly, men reported a sense of social stigmatization and isolation. Many men with PD found it hard to discuss this condition with their health care professionals, their partners, or their friends, leaving them feeling chronically stigmatized and socially isolated over time.

Case Study

Bob was a 45-year-old man who developed PD. During a sexual encounter with his wife, he stated that he “injured his penis” followed by a significant amount of pain and bleeding. Following this penile injury, he reported about 30 degrees of curvature. He presented to a sexual medicine clinic for treatment of his PD, and at the time his wife strongly suggested he see a mental health professional. He and his wife reported that he was depressed as a result of the PD and that he was spending less time with his family, which included his wife and his two young children. Bob indicated that he did not enjoy playing with his children, that he felt “different” than other men, and that he could not talk about his PD with anyone because he was fearful of what they would say and who they might tell. He was started on intralesional verapamil injections to treat the PD, and during this time, he continued to report significant frustration related to his PD. He continued to feel isolated and felt like he had a “disease” that no one had heard about and the treatment for which was like some “medieval torture.”

He eventually agreed to see a psychologist to address his PD-related distress. Bob’s therapy focused on helping the patient reengage in sexual relations with his wife. He was afraid to attempt intercourse because he feared reinjuring his penis and was anxious that he would not be able to please his wife sexually or that his attempts would end in failure. His therapy also focused on helping him feel less isolated. He eventually identified one friend who he could confide in about his PD, providing an important sounding board in the recovery process. Eventually, Bob’s depression lifted during treatment, and he was able to see that there were many important and meaningful aspects of his life and that he could continue to have a meaningful sex life with his wife.

References

  1. 1.

    Gelbard MK, Dorey F, James K. The natural history of Peyronie’s disease. J Urol. 1990;144(6):1376–9.

  2. 2.

    Smith JF, et al. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med. 2008;5(9):2179–84.

  3. 3.

    Nelson CJ, et al. The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008;5(8):1985–90.

  4. 4.

    Rosen R, et al. Impact of Peyronie’s disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008;5(8):1977–84.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chandrasoma, S.T., Gelbard, M.K. (2016). Peyronie’s Disease and Other Anatomical Disorders. In: Lipshultz, L., Pastuszak, A., Goldstein, A., Giraldi, A., Perelman, M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3100-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3100-2_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3099-9

  • Online ISBN: 978-1-4939-3100-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics